<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02831270</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160004-1</org_study_id>
    <nct_id>NCT02831270</nct_id>
  </id_info>
  <brief_title>Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery</brief_title>
  <official_title>Does Acute Normovolemic Hemodilution Affect Intraoperative Value of Serum-creatinine Concentration in Patients Undergoing Cardiac Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Serum-creatinine level (s-Cr) is an important factor for predicting perioperative patient's
      outcome regarding acute kidney injury. Although cardiopulmonary bypass (CPB), an essential
      procedure for cardiac surgery, dilutes patient's blood components, possible impact of
      applying acute normovolemic hemodilution (ANH) and CPB on s-Cr has not been well
      investigated.

      In patients undergoing cardiac surgery employing moderate hypothermic CPB (age 20-71 years,
      n=32), ANH will be randomly applied to 15 patients (Group-ANH) but not in 17 patients
      (Group-C) before initiating CPB. For ANH procedure consisting of 5 ml/kg of blood salvage and
      administering 5 ml/kg of balanced hydroxyethyl starch (HES) 130/0.4 for 15 min will be
      started at 30 min after anesthesia induction and before CPB application for surgery. In both
      groups, moderate hypothermic CPB will be initiated by using 1600-1800 ml of bloodless priming
      solution. The changes of hematocrit (Hct), Na+, K+, HCO3-, Ca2+, osmolarity, s-Cr will be
      determined before ANH (T1), after the first ANH of 2.5 ml/kg (T2), and after the second ANH
      of 2.5 ml/kg (T3), 30 sec and 60 sec after the initiation of CPB (T4, T5), immediately and 1
      hour after the weaning from CPB (T6, T7) and at the end of surgery (T8). S-Cr will be
      determined by using a point-of-care test device (StatSensorâ„¢ Creatinine, Nova Biomedical,
      USA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serum creatinine (s-Cr) concentration</measure>
    <time_frame>before ANH</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">32</enrollment>
  <condition>Mitral Regurgitation</condition>
  <condition>Mitral Stenosis</condition>
  <condition>Tricuspid Regurgitation</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Patients undergoing cardiac surgery supposed not to get acute normovolemic hemodilution (ANH) before CPB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Comparator: Acute normovolemic hemodilution group</arm_group_label>
    <description>Patients undergoing cardiac surgery supposed to get aucte normovolemic hemodilution (ANH) before CPB</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acute normovolemic hemodilution (ANH)</intervention_name>
    <arm_group_label>Active Comparator: Acute normovolemic hemodilution group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hydroxyethyl starch (HES 130/0.6)</intervention_name>
    <arm_group_label>Active Comparator: Acute normovolemic hemodilution group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing elective cardiac surgery due to valvular heart disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing cardiac surgery with cardiopulmonary bypass who signed written
             informed consent

        Exclusion Criteria:

          -  preoperative renal failure requiring reran replacement therapy

          -  preoperative liver disease

          -  preoperative low cardiac output (EF &lt; 50%)

          -  Preoperative IABP application, Atrial fibrillation, Pacemaker,

          -  contraindication for applying TEE

          -  intraoperative withdrawal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>143-729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2016</study_first_submitted>
  <study_first_submitted_qc>July 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2016</study_first_posted>
  <last_update_submitted>July 10, 2016</last_update_submitted>
  <last_update_submitted_qc>July 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>acute normovolemic hemodilution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
    <mesh_term>Mitral Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

